- Published on: March 27, 2024
- 10:43
Moscow, Mar 27 (Prensa Latina) The Russian Federal Medical and Biological Agency (FMBA) reported that it received a certificate of permanent registration for the drug Mir-19 against the disease caused by the SARS-CoV-2 Coronavirus.
